Harbin Medical University

This large study aims to see if using a detailed heart scan (coronary CTA) to guide treatment is better than standard care at preventing heart attacks, strokes, and death in high-risk adults in rural China. Nearly 15,000 people aged 40-75 with high cholesterol, diabetes, or kidne…

This study is testing whether a new combination of two drugs can help control advanced colorectal cancer that has stopped responding to standard treatments. It will involve about 18 patients whose cancer has specific immune markers. The goal is to see if this combination can shri…

This study is testing a new combination of three drugs for advanced triple-negative breast cancer that has progressed after initial treatment. It will enroll 12 patients to see if adding an anti-fibrosis drug (pirfenidone) to an immunotherapy (camrelizumab) and chemotherapy can h…

This study is testing a new combination of four drugs given before surgery for early, high-risk triple-negative breast cancer. The goal is to see if this combination can shrink or eliminate the tumor more effectively. The study will enroll 20 women to receive immunotherapy and ch…

This study is testing a 6-week mobile app program designed to help parents and caregivers of children with autism. The app uses interactive stories and therapy-based exercises. Researchers want to see if using the app reduces caregivers' stress, anxiety, and feelings of burnout c…